BCT.TO - BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp.
Bellevue Centre
Suite 300 235 West 15th Street
West Vancouver, BC V7T 2X1
Canada
https://www.briacell.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. William V. Williams M.D. | CEO, Pres & Director | 710.99k | N/A | 1957 |
| Mr. Gadi Levin B.Com., C.A., CPA, M.B.A., MBA | CFO & Corp. Sec. | 247.09k | N/A | 1973 |
| Dr. Miguel A. Lopez-Lago | Chief Scientific Officer | 246.62k | N/A | 1969 |
| Dr. Giuseppe Del Priore M.D., M.P.H., MPH | Chief Medical Officer | 438.86k | N/A | 1962 |
| Dr. Charles Louis Wiseman FACP, M.D. | Founder, Principal Research Advisor & Member of Scientific Advisory Board | N/A | N/A | 1946 |
Description
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Corporate Governance
BriaCell Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
